ph365.com promotion
ph365.com promotion
ph365.com promotion
Abu Dhabi is set to host the Global Media Congress 2024, where an agenda teeming with groundbreaking discussions has been unveiled. Patronized by Sheikh Mansour bin Zayed Al Nahyan, the event promises significant insights into the media industry's future, featuring key panels and sessions tackling critical issues faced by media professionals today. The opening keynote session, 'What Keeps You Up at Night?' will dive into pressing matters such as media credibility, digital transformation, and ethical AI use. Current global security concerns and urban leadership issues will also be part of the discourse. A session dedicated to 'The Digital Generation' aims to explore the impact of digital media on youth and how communication strategies can adapt to technological changes. Discussions on 'Emerging News Models' will examine the transformative role of technology and social media in news production and distribution. Another session, 'The AI-Powered Newsroom,' will highlight AI's potential to enhance journalistic efficiency and address ethical challenges like bias and misinformation. As the day progresses, sessions will focus on media innovations for digital-native audiences and explore cutting-edge strategies in film and digital entertainment. (With inputs from agencies.)
American and European stock markets mostly rose on Wednesday after inflation data cemented expectations that the US Federal Reserve will trim interest rates next month. While the Dow fell slightly, the other two major US indices advanced, led by the tech-rich Nasdaq, which piled on almost two percent to close above 20,000 points for the first time. The consumer price index (CPI) rose to 2.7 percent last month from a year ago, up slightly from 2.6 percent in October. "With the CPI numbers broadly in line, it is likely that the Fed will not be derailed and will cut rates again next week," Jochen Stanzl, chief market analyst at CMC Markets. "The data is not a showstopper for the current bull run on Wall Street," he added. Ahead of the data, investors priced in an 86 percent chance the Fed will cut interest rates next week by a quarter percentage point. That rose to more than 98 percent after the CPI data was published. Stocks in Paris and Frankfurt rose ahead of the European Central Bank's own interest rate announcement on Thursday, with analysts expecting another cut as it seeks to boost eurozone growth. Investors are also eyeing political developments in France, where officials said President Emmanuel Macron aims to name a new prime minister "within 48 hours" as he seeks to end political deadlock following the ouster of Michel Barnier. In company news, shares in German retail giant Zalando shed more than four percent on Frankfurt's DAX index, after it acquired domestic rival About You in a deal worth around 1.1 billion euros ($1.2 billion). Shares in Zara owner Inditex slid more than six percent after a record quarterly profit for the group fell short of market estimates. Among US companies, Google parent Alphabet earned 5.5 percent as it announced the launch of Gemini 2.0, its most advanced artificial intelligence model to date. That added to gains after Google also announced Tuesday details of a breakthrough quantum chip. Shares in Shanghai rose but Hong Kong gave up an early rally to end in the red. Traders were keeping tabs on China to see if it will announce further measures to support its struggling economy as leaders were to gather Wednesday for a conference to hammer out next year's agenda. President Xi Jinping and other top leaders on Monday announced their first major shift in policy for more than a decade, saying they would "implement a more active fiscal policy and an appropriately relaxed" strategy. Those remarks sparked hopes for more interest rate cuts and the freeing up of more cash for lending. New York - Dow: DOWN 0.2 percent at 44,148.56 (close) New York - S&P 500: UP 0.8 percent at 6,084.19 (close) New York - Nasdaq Composite: UP 1.8 percent at 20,034.89 (close) London - FTSE 100: UP 0.3 percent at 8,301.62 (close) Paris - CAC 40: UP 0.4 percent at 7,423.40 (close) Frankfurt - DAX: UP 0.3 percent at 20,399.16 (close) Tokyo - Nikkei 225: FLAT at 39,372.23 (close) Hong Kong - Hang Seng Index: DOWN 0.8 percent at 20,155.05 (close) Shanghai - Composite: UP 0.3 percent at 3,432.49 (close) Euro/dollar: DOWN at $1.0498 from $1.0527 on Tuesday Pound/dollar: DOWN at $1.2752 from $1.2771 Dollar/yen: UP at 152.40 yen from 151.95 yen Euro/pound: DOWN at 82.31 from 82.42 pence Brent North Sea Crude: UP 1.8 percent at $73.52 per barrel West Texas Intermediate: UP 2.4 percent at $70.29 per barrel burs-jmb/mlm
LARAMIE – Gov. Mark Gordon recently toured the Plant Growth and Phenotyping Facility at the University of Wyoming Center for Controlled Environment Agriculture (CEA). The governor was briefed regarding the center’s interdisciplinary course offerings, partnerships and commercialization potential by Mike Baldwin, greenhouse and genotyping manager; Parag Chitnis, vice president of UW Research and Economic Development; and Curtis Biggs, senior director of strategic partnerships. Following foundational support from the Wyoming Innovation Partnership (WIP), the established program attracted additional investment from the National Science Foundation. With the additional funding, the center is able to bring together faculty, staff and students from the College of Engineering and Physical Science, School of Computing, College of Agriculture, Life Science and Natural Resources, and College of Business, with the goal of developing a cross-disciplinary workforce for Controlled Environment Agriculture, industry and community engagement. “It is gratifying to see that ‘Wyoming’ is becoming synonymous with the word ‘innovation’ nationally and internationally. The interdisciplinary coursework at the Plant Growth and Phenotyping lab, and its internship opportunity serves students statewide who seek a career in controlled environment agriculture while still adding to innovation in conventional agriculture,” Gordon said in a news release. “WIP’s investment planted seeds for new technologies and economic opportunities in Wyoming – and the impact from this initial investment is fostering new industry partnerships and commercialization opportunities. This is exactly what land grant universities are meant to do.” Launched by Gordon in 2021, WIP is a collaboration to align education and workforce development and support innovation, entrepreneurship and research to help drive Wyoming's economy. The UW Center for CEA utilized initial WIP funding to purchase phenotyping instrumentations, secure expert personnel and develop a new course — CEA Research and Internship — that enables students to engage with instructors from six different departments including: Plant Science, the Science Initiative and Botany; Electrical Engineering; Accounting and Finance; Family and Consumer Science; Engineering; and the School of Computing. More information on the Wyoming Innovation Partnership can be found at wip.wyo.gov . Get any of our free email newsletters — news headlines, sports, arts & entertainment, state legislature, CFD news, and more.
Passenger from B.C. had 10 kg of Christmas-wrapped meth: New Zealand border agency VANCOUVER — New Zealand's border agency says a woman is in custody after arriving on a flight from Vancouver with more than 10 kilograms of methamphetamine wrapped as Christmas presents. The Canadian Press Dec 10, 2024 12:52 PM Dec 10, 2024 1:05 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Drugs wrapped like presents are shown at the Aukland Airport in Aukland, New Zealand in this recent handout photo. New Zealand Customs Service say a woman is in custody after arriving on a flight from Vancouver with gift-wrapped drugs in her luggage. THE CANADIAN PRESS/HO - Facebook, New Zealand Customs VANCOUVER — New Zealand's border agency says a woman is in custody after arriving on a flight from Vancouver with more than 10 kilograms of methamphetamine wrapped as Christmas presents. The New Zealand Customs Service says in a news release that the woman arrived in Auckland on Sunday, where she was questioned by officers. It says they conducted a bag search and found the 10.2 kg of drugs, which the release shows as five parcels in red wrapping paper decorated with snowflakes. It says customs officials estimate the drugs have a street value of up to NZ$3.8 million, which is about C$3.1 million. They say the woman has appeared in Manukau District Court and faces charges of importation and possession for supply of a "Class A" controlled drug. The border agency calls it a "classic attempt" by organized transnational criminals to "exploit the busy travel season." “These criminal groups make the mistake of thinking Customs won’t chase smaller targets, but we know that drugs sent from North America are an increasing risk and we are prepared," the release says. "We also have an excellent working relationship with our Canadian partners and collaborate with them closely to, in some cases, stop the drug couriers even before they board a flight here.” This report by The Canadian Press was first published Dec. 10, 2024. The Canadian Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More The Mix Premiers to meet with Trudeau Wednesday about trade and tariffs, Ford says Dec 10, 2024 1:34 PM Who is Tony Buzbee, the lawyer suing Jay-Z as part of civil cases against Sean 'Diddy' Combs? Dec 10, 2024 1:29 PM S&P/TSX composite down more than 100 points Tuesday, U.S. stock markets also lower Dec 10, 2024 1:25 PM Featured Flyer
‘Tale of two leaders’: Jewish community leader praises Minns, blasts AlbaneseAmerican and European stock markets mostly rose on Wednesday after inflation data cemented expectations that the US Federal Reserve will trim interest rates next month. While the Dow fell slightly, the other two major US indices advanced, led by the tech-rich Nasdaq, which piled on almost two percent to close above 20,000 points for the first time. The consumer price index (CPI) rose to 2.7 percent last month from a year ago, up slightly from 2.6 percent in October. "With the CPI numbers broadly in line, it is likely that the Fed will not be derailed and will cut rates again next week," Jochen Stanzl, chief market analyst at CMC Markets. "The data is not a showstopper for the current bull run on Wall Street," he added. Ahead of the data, investors priced in an 86 percent chance the Fed will cut interest rates next week by a quarter percentage point. That rose to more than 98 percent after the CPI data was published. Stocks in Paris and Frankfurt rose ahead of the European Central Bank's own interest rate announcement on Thursday, with analysts expecting another cut as it seeks to boost eurozone growth. Investors are also eyeing political developments in France, where officials said President Emmanuel Macron aims to name a new prime minister "within 48 hours" as he seeks to end political deadlock following the ouster of Michel Barnier. In company news, shares in German retail giant Zalando shed more than four percent on Frankfurt's DAX index, after it acquired domestic rival About You in a deal worth around 1.1 billion euros ($1.2 billion). Shares in Zara owner Inditex slid more than six percent after a record quarterly profit for the group fell short of market estimates. Among US companies, Google parent Alphabet earned 5.5 percent as it announced the launch of Gemini 2.0, its most advanced artificial intelligence model to date. That added to gains after Google also announced Tuesday details of a breakthrough quantum chip. Shares in Shanghai rose but Hong Kong gave up an early rally to end in the red. Traders were keeping tabs on China to see if it will announce further measures to support its struggling economy as leaders were to gather Wednesday for a conference to hammer out next year's agenda. President Xi Jinping and other top leaders on Monday announced their first major shift in policy for more than a decade, saying they would "implement a more active fiscal policy and an appropriately relaxed" strategy. Those remarks sparked hopes for more interest rate cuts and the freeing up of more cash for lending. New York - Dow: DOWN 0.2 percent at 44,148.56 (close) New York - S&P 500: UP 0.8 percent at 6,084.19 (close) New York - Nasdaq Composite: UP 1.8 percent at 20,034.89 (close) London - FTSE 100: UP 0.3 percent at 8,301.62 (close) Paris - CAC 40: UP 0.4 percent at 7,423.40 (close) Frankfurt - DAX: UP 0.3 percent at 20,399.16 (close) Tokyo - Nikkei 225: FLAT at 39,372.23 (close) Hong Kong - Hang Seng Index: DOWN 0.8 percent at 20,155.05 (close) Shanghai - Composite: UP 0.3 percent at 3,432.49 (close) Euro/dollar: DOWN at $1.0498 from $1.0527 on Tuesday Pound/dollar: DOWN at $1.2752 from $1.2771 Dollar/yen: UP at 152.40 yen from 151.95 yen Euro/pound: DOWN at 82.31 from 82.42 pence Brent North Sea Crude: UP 1.8 percent at $73.52 per barrel West Texas Intermediate: UP 2.4 percent at $70.29 per barrel burs-jmb/mlmHarry and Meghan’s polo docuseries to highlight ‘grit behind the glamour’
Natixis Advisors LLC increased its position in Natera, Inc. ( NASDAQ:NTRA – Free Report ) by 26.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,051 shares of the medical research company’s stock after acquiring an additional 6,467 shares during the quarter. Natixis Advisors LLC’s holdings in Natera were worth $3,942,000 at the end of the most recent quarter. Several other hedge funds also recently bought and sold shares of NTRA. Farallon Capital Management LLC raised its holdings in shares of Natera by 13.6% in the 2nd quarter. Farallon Capital Management LLC now owns 4,460,557 shares of the medical research company’s stock valued at $483,034,000 after acquiring an additional 532,874 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Natera by 6.6% in the second quarter. Massachusetts Financial Services Co. MA now owns 2,397,582 shares of the medical research company’s stock valued at $259,634,000 after purchasing an additional 148,917 shares in the last quarter. Duquesne Family Office LLC grew its stake in shares of Natera by 2.4% during the second quarter. Duquesne Family Office LLC now owns 1,974,880 shares of the medical research company’s stock valued at $213,860,000 after buying an additional 45,500 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Natera by 25.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,229,558 shares of the medical research company’s stock worth $156,092,000 after buying an additional 246,246 shares during the period. Finally, Driehaus Capital Management LLC lifted its stake in shares of Natera by 14.6% in the 2nd quarter. Driehaus Capital Management LLC now owns 1,220,768 shares of the medical research company’s stock valued at $132,197,000 after acquiring an additional 155,802 shares during the last quarter. Hedge funds and other institutional investors own 99.90% of the company’s stock. Natera Price Performance Shares of NTRA stock opened at $167.26 on Friday. The business’s fifty day moving average is $131.54 and its 200 day moving average is $117.85. The company has a quick ratio of 4.23, a current ratio of 4.39 and a debt-to-equity ratio of 0.33. The stock has a market cap of $22.08 billion, a price-to-earnings ratio of -95.03 and a beta of 1.53. Natera, Inc. has a twelve month low of $53.62 and a twelve month high of $171.95. Wall Street Analyst Weigh In NTRA has been the topic of a number of analyst reports. Piper Sandler lifted their price target on Natera from $150.00 to $200.00 and gave the stock an “overweight” rating in a research note on Monday, November 18th. Robert W. Baird upped their price target on shares of Natera from $120.00 to $160.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. TD Cowen increased their price target on shares of Natera from $155.00 to $175.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. BTIG Research boosted their price objective on shares of Natera from $125.00 to $135.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Craig Hallum raised their target price on Natera from $121.00 to $157.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating and seventeen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $140.59. View Our Latest Research Report on Natera Insiders Place Their Bets In other news, insider Jonathan Sheena sold 2,700 shares of Natera stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of $127.57, for a total value of $344,439.00. Following the completion of the transaction, the insider now owns 284,741 shares of the company’s stock, valued at $36,324,409.37. The trade was a 0.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website . Also, insider Solomon Moshkevich sold 256 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $120.07, for a total transaction of $30,737.92. Following the completion of the transaction, the insider now owns 111,891 shares in the company, valued at approximately $13,434,752.37. The trade was a 0.23 % decrease in their position. The disclosure for this sale can be found here . Over the last quarter, insiders have sold 46,503 shares of company stock worth $6,325,804. 7.60% of the stock is currently owned by company insiders. Natera Profile ( Free Report ) Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. Featured Stories Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter .
